SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).
Saved in:
| Title: | SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). |
|---|---|
| Authors: | Sábato S; Fundació Lluita Contra Les Infeccions, Badalona, Spain.; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Benet S; Fundació Lluita Contra Les Infeccions, Badalona, Spain.; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Rogers AJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, CA, USA., Murray TA; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA., Skeans M; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA., Mothe B; Fundació Lluita Contra Les Infeccions, Badalona, Spain.; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; IrsiCaixa, Badalona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases and Immunity, University of Vic - Central University of Catalonia (UVic-UCC), Barcelona, Spain., Paredes R; Fundació Lluita Contra Les Infeccions, Badalona, Spain.; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; IrsiCaixa, Badalona, Spain., Mourad A; Division of Infectious Diseases, Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Kiweewa F; Strengthening Institutional Capacity for Research Administration (SICRA), Lira, Uganda.; Lira Regional Referral Hospital, Lira, Uganda., Kamel D; UT Southwestern Medical Center, Dallas, TX, USA., Jain MK; UT Southwestern Medical Center, Dallas, TX, USA., Lutaakome J; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda., Nalubega MG; Strengthening Institutional Capacity for Research Administration (SICRA), Lira, Uganda., Sebudde N; Strengthening Institutional Capacity for Research Administration (SICRA), Lira, Uganda.; Lira Regional Referral Hospital, Lira, Uganda., Mylonakis E; Department of Medicine, Houston Methodist Hospital, Houston, TX, USA., Braun DL; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland., Hatlen T; The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Kimuli I; Makerere University Lung Institute, Makerere University, Kampala, Uganda., Kitko C; Joint Clinical Research Centre, Lubowa, Uganda., Mugerwa H; Joint Clinical Research Centre, Lubowa, Uganda., Kitonsa J; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda., Kim K; Tampa General Hospital, University of South Florida, Tampa, FL, USA., Tien PC; Department of Medicine, Department of Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA, USA., Highbarger J; NIAID, NIH, FNL (Frederick National Laboratory), Frederick, ML, USA., McCormack AL; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Sanchez A; Infectious Diseases Section, VA Medical Center, Washington, DC, USA., Murray DD; Department of Infectious Diseases, CHIP Center of Excellence for Health, Immunity, and Infections, Rigshospitalet, Copenhagen, Denmark., Babiker AG; MRC Clinical Trials Unit at UCL, University College London, London, UK., Davey VJ; Office of Research and Development, US Department of Veterans Affairs, Washington, DC, USA., Files DC; Division of Pulmonary, Critical Care, Allergy and Immunology, Department of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Gelijns AC; Department of Population Health Science and Policy, Icahn School of Medicine, New York, NY, USA., Higgs ES; Division of Clinical Research, NIAID, NIH, Bethesda, USA., Kan VL; VA Medical Center, George Washington University, Washington, DC, USA., Matthews GV; Kirby Institute, University of New South Wales, Sydney, Australia., Pett SL; MRC Clinical Trials Unit at UCL, University College London, London, UK., Lane HC; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, USA., Reilly C; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA., Goodman AL; MRC Clinical Trials Unit at UCL, University College London, London, UK.; Department of Infection at Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK., Lundgren JD; Department of Infectious Diseases, CHIP Center of Excellence for Health, Immunity, and Infections, Rigshospitalet, Copenhagen, Denmark., Moltó J; Fundació Lluita Contra Les Infeccions, Badalona, Spain. jmolto@lluita.org.; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmolto@lluita.org.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. jmolto@lluita.org. |
| Corporate Authors: | ACTIV-3/VATICO study group and the STRIVE Network |
| Source: | Scientific reports [Sci Rep] 2025 Mar 22; Vol. 15 (1), pp. 9882. Date of Electronic Publication: 2025 Mar 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-025-92742-x |
